These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 26526233)

  • 1. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
    Yan Y; Jiang X; Zhao Y; Wen H; Liu G
    Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells.
    Yan Y; Liu H; Wen H; Jiang X; Cao X; Zhang G; Liu G
    Mol Cell Biochem; 2013 Jun; 378(1-2):1-7. PubMed ID: 23580092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPER.
    Boscaro C; Ramaschi GE; Trevisi L; Cignarella A; Bolego C
    Life Sci; 2023 Nov; 333():122135. PubMed ID: 37778413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells.
    Liu H; Yan Y; Wen H; Jiang X; Cao X; Zhang G; Liu G
    Cell Biol Int; 2014 May; 38(5):631-8. PubMed ID: 24446390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
    Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
    Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPER/ERK&AKT/NF-κB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells.
    Zhu P; Liao LY; Zhao TT; Mo XM; Chen GG; Liu ZM
    Mol Cell Endocrinol; 2017 Feb; 442():68-80. PubMed ID: 27940299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.
    Ahn JH; Lee KT; Choi YS; Choi JH
    Prostaglandins Other Lipid Mediat; 2018 Jan; 134():47-56. PubMed ID: 29292033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of estrogen receptor beta in ovarian carcinogenesis.
    Bardin A; Hoffmann P; Boulle N; Katsaros D; Vignon F; Pujol P; Lazennec G
    Cancer Res; 2004 Aug; 64(16):5861-9. PubMed ID: 15313930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of G-Protein-Coupled Estrogen Receptor Inhibits the Migration of Human Nonsmall Cell Lung Cancer Cells via IKK-β/NF-κB Signals.
    Zhu G; Huang Y; Wu C; Wei D; Shi Y
    DNA Cell Biol; 2016 Aug; 35(8):434-42. PubMed ID: 27082459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-expression of estrogen receptor β inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells.
    Zhu J; Hua K; Sun H; Yu Y; Jin H; Feng Y
    Oncol Rep; 2011 Dec; 26(6):1497-503. PubMed ID: 21874257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of ARK5 expression suppresses invasion of ovarian cancer cells.
    Wang S; Li S; Wang H; Li W; Gao Y; Wang X; Fang C; Zhang B; Sun X; Li R; Shi W; Chen M; Shi L
    Mol Med Rep; 2019 Apr; 19(4):2927-2934. PubMed ID: 30720082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPER Mediates Non-Genomic Effects of Estrogen.
    Pupo M; Maggiolini M; Musti AM
    Methods Mol Biol; 2016; 1366():471-488. PubMed ID: 26585158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers.
    Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
    Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G Protein-Coupled Estrogen Receptor Mediates Cell Proliferation through the cAMP/PKA/CREB Pathway in Murine Bone Marrow Mesenchymal Stem Cells.
    Chuang SC; Chen CH; Chou YS; Ho ML; Chang JK
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The G-Protein-Coupled Estrogen Receptor Selective Agonist G-1 Attenuates Cell Viability and Migration in High-Grade Serous Ovarian Cancer Cell Lines.
    Hanafi D; Onyenwoke RU; Kimbro KS
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
    Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
    BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER).
    Feldman RD; Ding Q; Hussain Y; Limbird LE; Pickering JG; Gros R
    FASEB J; 2016 Jun; 30(6):2086-96. PubMed ID: 26911792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
    Zou M; Zhang X; Xu C
    Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.